Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 118
Filter
1.
Int J Oral Maxillofac Surg ; 48(5): 567-575, 2019 May.
Article in English | MEDLINE | ID: mdl-30447876

ABSTRACT

Limited information about salvage surgery is available for locally persistent and recurrent maxillary sinus cancers after the completion of chemoradiation therapy. Seventy-six maxillary sinus cancer patients who had undergone chemoradioselection using initial radiotherapy and concomitant intra-arterial cisplatin were screened retrospectively. Twenty-four of these patients who had a locally persistent or recurrent tumour were investigated. The 2-year overall survival rate of patients with maxillary sinus cancer of all types was 39.0% for those who underwent salvage surgery and 10.0% for those who did not. The 2-year overall survival rate of patients with maxillary sinus squamous cell carcinoma was 45.8% for those who underwent salvage surgery and 11.1% for those who did not. Furthermore, the 2-year local control and overall survival rates of patients with positive and negative surgical margins were 14.3% and 83.3% and 14.3% and 66.7%, respectively. There were significant differences in local control (P=0.004) and overall survival (P=0.005) regarding surgical margin status. Although salvage surgery for a locally persistent or recurrent maxillary sinus cancer is a feasible treatment, patients with positive surgical margins are more prone to local relapse. Therefore, surgical safety margins should be assessed thoroughly.


Subject(s)
Carcinoma, Squamous Cell , Cisplatin , Humans , Margins of Excision , Neoplasm Recurrence, Local , Recurrence , Retrospective Studies , Salvage Therapy
2.
Clin Genet ; 94(2): 232-238, 2018 08.
Article in English | MEDLINE | ID: mdl-29700822

ABSTRACT

Leukoencephalopathies encompass all clinical syndromes that predominantly affect brain white matter. Genetic diagnosis informs clinical management of these patients, but a large part of the genetic contribution to adult leukoencephalopathy remains unresolved. To examine this genetic contribution, we analyzed genomic DNA from 60 Japanese patients with adult leukoencephalopathy of unknown cause by next generation sequencing using a custom-designed gene panel. We selected 55 leukoencephalopathy-related genes for the gene panel. We identified pathogenic mutations in 8 of the 60 adult leukoencephalopathy patients (13.3%): NOTCH3 mutations were detected in 5 patients, and EIF2B2, CSF1R, and POLR3A mutations were found independently in 1 patient each. These results indicate that cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) caused by NOTCH3 mutations is the most frequent adult leukoencephalopathy in our cohort. Moreover, brain imaging analysis indicates that CADASIL patients who do not present typical phenotypes may be underdiagnosed if not examined genetically.


Subject(s)
CADASIL/genetics , Genetic Predisposition to Disease , Leukoencephalopathies/genetics , Receptor, Notch3/genetics , Adolescent , Adult , Aged , Aged, 80 and over , CADASIL/diagnostic imaging , CADASIL/physiopathology , Cohort Studies , Eukaryotic Initiation Factor-2B/genetics , Genetic Testing , Humans , Leukoencephalopathies/diagnostic imaging , Leukoencephalopathies/physiopathology , Magnetic Resonance Imaging , Middle Aged , Mutation , Phenotype , RNA Polymerase III/genetics , Receptors, Granulocyte-Macrophage Colony-Stimulating Factor/genetics , Exome Sequencing
3.
Eur J Pain ; 21(7): 1144-1153, 2017 08.
Article in English | MEDLINE | ID: mdl-28169489

ABSTRACT

BACKGROUND: This prospective study was designed to examine the associations of demographic, clinical, psychological and neuroendocrine factors with acute and chronic post-operative pain following partial mastectomy. METHODS: Sixty-four female patients scheduled for partial mastectomy were enrolled. Pre-operative anxiety/depression was assessed, using the Hospital Anxiety and Depression Scale (HADS). Pre-operative 24-h urinary cortisol levels were measured 2 days before surgery. Post-operative pain was examined using a visual analog scale (VAS) for acute pain on 0-2 post-operative day (POD), and a short-form McGill Pain Questionnaire for chronic pain at 6 months after surgery. In the last 29 subjects, post-operative 24-h urinary cortisol levels were also measured on 0 POD and were subjected to correlation analysis. RESULTS: Multivariate logistic regression analysis revealed that lower pre-operative cortisol secretion and greater pre-operative anxiety were significantly associated with an increased risk of moderate to severe acute post-operative pain [Odds Ratio (95% Confidence Interval); 0.96 (0.92-0.98), and 1.24 (1.04-1.54)], and that patients with greater pre-operative anxiety and moderate to severe acute pain were more likely to develop chronic post-operative pain [OR (95% CI); 1.63 (1.23-2.40), and 5.07 (1.30-24.6)]. Correlational analysis demonstrated that the post-operative cortisol level was inversely correlated with pre-operative anxiety and the intensity of acute post-operative pain (r = -0.40, p < 0.05, and r = -0.50, p < 0.01), but not with the intensity of chronic pain. CONCLUSIONS: This study confirms that pre-operative anxiety is associated with both acute and chronic post-operative pain after partial mastectomy. It also suggests that lower perioperative cortisol secretion might be associated with greater acute post-operative pain. SIGNIFICANCE: Although the associations between psychological stress/stress hormone levels and chronic post-operative pain remain to be determined, pre-operative psychological stress and perioperative cortisol levels are correlated with acute post-operative pain.


Subject(s)
Acute Pain/physiopathology , Anxiety Disorders/complications , Anxiety/psychology , Chronic Pain/complications , Depression/psychology , Pain, Postoperative/etiology , Humans , Mastectomy , Pain Measurement , Prospective Studies , Stress, Psychological
4.
Eur J Neurol ; 24(2): 366-373, 2017 02.
Article in English | MEDLINE | ID: mdl-27933692

ABSTRACT

BACKGROUND AND PURPOSE: In myotonic dystrophy type 1 (DM1), weakness of distal limb muscles affects quality of life. Non-invasive evaluation of muscular involvement by muscle sonography could be useful for characterizing muscle-specific involvement. METHODS: Sonography of the lower leg and forearm was performed in 19 patients with DM1 and 10 control subjects. The mean echo intensities (EIs) of seven limb muscles were obtained by computer-assisted histogram analysis and compared within DM1 according to the overall clinical severity. RESULTS: The EIs of the muscles were significantly higher in DM1 than in the controls (P < 0.01), except for the soleus (P = 0.4). Comparison of adjacent muscles showed the following: (i) greater EIs in flexor digitorum profundus than flexor carpi ulnaris (P < 0.01) and flexor digitorum superficialis (P = 0.02), and (ii) greater EIs in the medial head of the gastrocnemius than the soleus (P < 0.00001). In a subgroup analysis of DM1 according to the modified Rankin Scale (mRS), the more severe subgroup (mRS = 4-5) had lower mean EIs than the less severe subgroup (mRS from 1-3) (P = 0.01) in the flexor digitorum superficialis but not in other muscles. CONCLUSIONS: Preferential high echogenicity in the medial gastrocnemius and deep finger flexors is suggestive of DM1. Muscle echogenicity is not generally related to functional dysfunction in DM1.


Subject(s)
Muscle, Skeletal/diagnostic imaging , Myotonic Dystrophy/diagnostic imaging , Adult , Aged , Female , Fingers/diagnostic imaging , Forearm/diagnostic imaging , Hand/diagnostic imaging , Humans , Image Processing, Computer-Assisted , Male , Middle Aged , Quality of Life , Ultrasonography , Young Adult
5.
Acta Anaesthesiol Scand ; 59(10): 1260-8, 2015 Nov.
Article in English | MEDLINE | ID: mdl-26079533

ABSTRACT

BACKGROUND: In this randomized controlled trial, we examined whether intra- and postoperative infusion of low-dose ketamine decreased postoperative morphine requirement and morphine-related adverse effects as nausea and vomiting after scoliosis surgery. METHODS: After IRB approval and informed consent, 36 patients, aged 10-19 years, undergoing posterior correction surgery for adolescent idiopathic scoliosis, were randomly allocated into two groups: intra- and postoperative ketamine infusion at a rate of 2 µg/kg/min until 48 h after surgery (ketamine group, n = 17) or infusion of an equal volume of saline (placebo group, n = 19). All patients were administered total intravenous anesthesia with propofol and remifentanil during surgery and intravenous morphine using a patient-controlled analgesia device after surgery. The primary outcome was cumulative morphine consumption in the initial 48 h after surgery. Pain scores (Numerical Rating Scale, NRS, 0-10), sedation scales, incidence of postoperative nausea and vomiting (PONV), and antiemetic consumption were recorded by nurses blinded to the study protocol for 48 h after surgery. RESULTS: Patient characteristics did not differ between the two groups. Cumulative morphine consumption for 48 h after surgery was significantly lower in the ketamine group compared to the placebo group (0.89 ± 0.08 mg/kg vs. 1.16 ± 0.07 mg/kg, 95% confidence interval for difference between the means, 0.03-0.48 mg/kg, P = 0.019). NRS pain, sedation scales, and incidence of PONV did not differ between the two groups. Antiemetic consumption was significantly smaller in ketamine group. CONCLUSIONS: Intra- and postoperative infusion of low-dose ketamine reduced cumulative morphine consumption and antiemetic requirement for 48 h after surgery.


Subject(s)
Ketamine/administration & dosage , Scoliosis/surgery , Adolescent , Child , Female , Humans , Male , Morphine/administration & dosage , Pain, Postoperative/prevention & control , Postoperative Nausea and Vomiting/prevention & control , Young Adult
6.
Allergy ; 59(5): 533-8, 2004 May.
Article in English | MEDLINE | ID: mdl-15080835

ABSTRACT

BACKGROUND: Using the sera from buckwheat (BW)-allergic patients, several putative causative molecules were reported. However, few molecules were determined on the molecular structure. We demonstrated in 2000 that the major allergen with 24 kDa (BW24KD) is a legumin-like storage protein. OBJECTIVE: The aim of this study was to isolate and characterize further a major allergen with 10 kDa by molecular cloning. METHODS AND RESULTS: Buckwheat allergens were identified by immunoblotting analysis using sera from 14 allergic and two nonallergic individuals. We identified a protein with 10 kDa (BW10KD) that reacted with immunoglobulin E (IgE) more strongly than with IgG and IgA in 57% of the allergic patients but not with IgE in nonallergic individuals. Analyses were performed by N-terminal amino acid sequencing and molecular cloning. Physiological significance was assessed by an immunoblotting experiment showing that the reactivity of an allergic patient's serum IgE to BW10KD was competitively inhibited by natural BW extracts. CONCLUSION: Molecular cloning experiments indicated that BW10KD as a BW allergen was a member of the 2S-albumin multigene family.


Subject(s)
Allergens/genetics , Allergens/immunology , Fagopyrum/immunology , Hypersensitivity/immunology , Immunoglobulin E/immunology , Adolescent , Adult , Aged , Allergens/chemistry , Allergens/isolation & purification , Amino Acid Sequence , Child , Child, Preschool , Fagopyrum/chemistry , Female , Humans , Immunoblotting , Male , Middle Aged , Molecular Sequence Data , Molecular Weight , Plant Extracts/chemistry
7.
J Endocrinol ; 172(2): 345-54, 2002 Feb.
Article in English | MEDLINE | ID: mdl-11834452

ABSTRACT

When isolated rat pancreatic islets are treated with 16.7 mM glucose, a time-dependent potentiation (TDP) of insulin release occurs that can be detected by subsequent treatment with 50 mM KCl. It has been thought that TDP by glucose is a Ca2+-dependent phenomenon and only occurs when exposure to glucose is carried out in the presence of Ca2+. In contrast to this, we now demonstrate TDP under stringent Ca2+-free conditions (Ca2+-free buffer containing 1 mM EGTA). In fact, under these Ca2+-free conditions glucose caused an even stronger TDP than in the presence of Ca2+. TDP induced by glucose in the absence of extracellular Ca2+ was unaffected by inhibitors of protein kinase C (PKC). However, cerulenin or tunicamycin, two inhibitors of protein acylation, eradicated TDP without affecting glucose metabolism. The TDP by glucose was not associated with an increase in the cytosolic free Ca2+ concentration ([Ca2+]i) during subsequent treatment with high K+. Exposure of islets to forskolin under Ca(2+)-free conditions did not cause TDP despite a large increase in the cellular cAMP levels. In conclusion, glucose alone induces TDP under stringent Ca2+-free conditions when [Ca2+]i was significantly lowered. Protein acylation is implicated in the underlying mechanism of TDP.


Subject(s)
Glucose/pharmacology , Insulin/metabolism , Islets of Langerhans/metabolism , Acylation/drug effects , Analysis of Variance , Animals , Calcium/metabolism , Calcium/pharmacology , Cells, Cultured , Cerulenin/pharmacology , Colforsin/pharmacology , Cyclic AMP/metabolism , Enzyme Inhibitors/pharmacology , Indoles/pharmacology , Insulin Secretion , Islets of Langerhans/drug effects , Male , Maleimides/pharmacology , Naphthalenes/pharmacology , Potassium Chloride/pharmacology , Protein Kinase C/antagonists & inhibitors , Rats , Rats, Wistar , Statistics, Nonparametric , Stimulation, Chemical , Tetradecanoylphorbol Acetate/pharmacology , Time Factors , Tunicamycin/pharmacology
8.
Hum Antibodies ; 11(4): 121-9, 2002.
Article in English | MEDLINE | ID: mdl-12775892

ABSTRACT

Human anti-IL-6 antibody may be useful for the immunotherapy of various inflammatory diseases, such as rheumatoid arthritis. Since IL-6 is a growth factor for B cell hybridoma, it is not easy to isolate murine B cell hybridomas producing the anti-IL-6 antibody with the IL-6-signaling inhibitory activity. In this study, the antibody library (Vgamma-Vkappa, Vgamma-Vlambda, Vmu-Vkappa or micro-Vlambda ligated into the pCANTAB 5E phagemid vector) was prepared from peripheral blood mononuclear cells of 20 healthy subjects. The phage display library was panned with an IL-6-coated plastic plate, and the binding specificity was confirmed by ELISA and BIAcore. From the antibody library (Vgamma-Vlambda), five IL-6-specific phage clones were isolated. The effects of the soluble scFvs purified from these phage clones were tested on the growth of the IL-6-dependent human cell line, KT-3. Two of these clones significantly inhibited the growth of KT-3, and three showed no inhibition.


Subject(s)
Antibody Specificity , Immunoglobulin Fragments/immunology , Interleukin-6/immunology , Signal Transduction/immunology , Amino Acid Sequence , Animals , Autoimmune Diseases/therapy , Cell Line , Enzyme-Linked Immunosorbent Assay , Humans , Immunoglobulin Fragments/blood , Immunoglobulin Fragments/genetics , Immunoglobulin Variable Region , Leukocytes, Mononuclear/immunology , Molecular Sequence Data , Peptide Library , Sequence Analysis, DNA , Surface Plasmon Resonance
10.
Osteoarthritis Cartilage ; 9(7): 664-70, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11597179

ABSTRACT

OBJECTIVE: Since most chondrocytes in articular cartilage are in the resting phase (G0) of the cell cycle, it has been difficult to investigate their cell kinetics using 3H-thymidine autoradiography, or immunohistochemistry. In the present study, DNA cytofluorometry, which is useful to analyse the cell kinetics even for such inactive cell populations as in the G0 phase, was applied to human chondrocytes of the articular cartilages under normal aging and pathologic conditions such as osteoarthritis (OA), rheumatoid arthritis (RA), and aseptic necrosis (AN). DESIGN: The human articular cartilages for the study were obtained from autopsy and surgical materials. Fifty joints were used for the study of aging, 54 for the study of OA, 20 for studying RA, and 10 for AN study. The isolated chondrocytes were quickly prepared from fresh articular cartilages, using a combination method of enzymatic digestion with papain and collagenase, followed by mechanical cell separation by churning and homogenization. RESULTS: The DNA histograms obtained by cytofluorometry with propidium-iodide staining showed that most chondrocytes had diploid DNA content (2c) in all cartilages studied, suggesting that they were in the G0 phase. However, there were a few chondrocytes having tetraploid DNA content (4c) in the normally aged articular cartilages, and there were some cells having DNA content between 2c and 4c in the diseased cartilages. The former cells were considered to be G0-phase cells of the 4c chondrocytes, while the latter cells were considered to be in the DNA synthetic (S) phase or G2-phase of the 2c chondrocytes. The frequency of 4c chondrocytes in aged cartilage was significantly increased, compared to that in the young cartilage. In contrast to the normal cartilage, the frequency of S- and G2-phase cells, which was expressed as the S- G2 index, in diseased cartilages (OA, RA and AN) was significantly high (P< 0.0001). In OA cartilage, the S-G2 index was much higher in the severe or moderate stage than in the mild stage, suggesting that the chondrocytes in clusters may actively proliferate. CONCLUSION: These results showed that in normal articular cartilages most chondrocytes are in the G0 phase, while some became 4c polyploid cells, and that these G0-phase chondrocytes had a potential to proliferate under diseased conditions.


Subject(s)
Aging/physiology , Arthritis, Rheumatoid/pathology , Chondrocytes/cytology , Osteoarthritis/pathology , Osteonecrosis/pathology , Adolescent , Adult , Aged , Aged, 80 and over , Cell Division/physiology , Cell Separation/methods , Child , Child, Preschool , Cytogenetic Analysis/methods , Diploidy , Female , Flow Cytometry/methods , Humans , Infant , Infant, Newborn , Male , Middle Aged
11.
Int Orthop ; 25(2): 104-6, 2001.
Article in English | MEDLINE | ID: mdl-11409446

ABSTRACT

Eight patients with locally aggressive giant cell tumor were treated with marginal resection and implantation of a ceramic endoprosthesis with a non-hinged knee joint. The patients have been followed-up for between 10 to 16 years. Newly formed bone appeared at the junction between implant and cortex and in 2 cases subsidence of the implant was seen. All the patients had good function of the knee and no revision was needed.


Subject(s)
Bone Neoplasms/surgery , Giant Cell Tumors/surgery , Knee Joint/physiopathology , Knee Prosthesis , Prosthesis Design , Adult , Aged , Bone Neoplasms/diagnostic imaging , Ceramics , Female , Follow-Up Studies , Giant Cell Tumors/diagnostic imaging , Humans , Knee Joint/diagnostic imaging , Male , Middle Aged , Radiography , Severity of Illness Index , Treatment Outcome
12.
J Antibiot (Tokyo) ; 54(4): 364-74, 2001 Apr.
Article in English | MEDLINE | ID: mdl-11426661

ABSTRACT

A systematic approach for improving the water-solubility of anti-MRSA (methicillin-resistant Staphylococcus aureus) cephalosporin derivatives is described. We first tried to improve the water-solubility of 7beta-[2-(5-amino-1,2,4-thiadiazol-3-yl)-2(Z)-fluoromethoxyiminoacetamido]-3-[(E)-2-(1-methylimidazo[1,2-b]pyridazinium-6-yl)thiovinyl]-3-cephem-4-carboxylate (1a) by substitution of the C-3' pharmacophore. Replacement of the C-3' pharmacophore with a 1-methyl-4-pyridinio group improved the water-solubility without decreasing the anti-MRSA activity. Furthermore, we applied the N-modified prodrug strategy to the C-7 acyl group in order to enhance the water-solubility drastically. Among the compounds prepared, the N-phosphono type prodrugs 2a(1-methylimidazo[1,2-b]pyridazinium derivative) and 2b (1-methyl-4-pyridinio derivative) showed water-solubility appropriate for a product intended for intravenous injection and in vivo anti-MRSA activity comparable to that of vancomycin.


Subject(s)
Bacterial Proteins , Carrier Proteins , Cephalosporins/pharmacology , Methicillin Resistance/physiology , Muramoylpentapeptide Carboxypeptidase , Prodrugs/pharmacology , Staphylococcus aureus/drug effects , Animals , Cephalosporins/administration & dosage , Cephalosporins/pharmacokinetics , Gram-Negative Bacteria/drug effects , Gram-Positive Bacteria/drug effects , Hexosyltransferases/metabolism , Hydrogen-Ion Concentration , Injections , Male , Mice , Mice, Inbred ICR , Microbial Sensitivity Tests , Multienzyme Complexes/metabolism , Penicillin-Binding Proteins , Peptidyl Transferases/metabolism , Prodrugs/administration & dosage , Prodrugs/pharmacokinetics , Protein Binding , Solubility , Spectrophotometry, Infrared
13.
Intern Med ; 40(4): 358-62, 2001 Apr.
Article in English | MEDLINE | ID: mdl-11334400

ABSTRACT

A 31-year-old woman displayed sleepiness and impairment of recent memory. T2-weighted MRI revealed high signal intensity lesions in the bilateral basal ganglia, thalamus, and brainstem. Although remission was achieved with corticosteroid therapy, she again displayed memory dysfunction and emotional disturbance one year later, at which time MRI disclosed new lesions in the right caudate nucleus and left frontal white matter. Corticosteroid therapy lead to improvement, and she suffered no recurrence on maintenance steroid therapy. These findings suggest that caudate lesions do occur in multiple sclerosis, the manifestations of which can be abulia and memory dysfunction, as in the present case.


Subject(s)
Caudate Nucleus/pathology , Multiple Sclerosis/pathology , Adrenal Cortex Hormones/therapeutic use , Adult , Blepharoptosis/etiology , Deglutition Disorders/etiology , Diplopia/etiology , Emotions , Facial Paralysis/etiology , Female , Humans , Magnetic Resonance Imaging , Memory Disorders/etiology , Mental Disorders/etiology , Multiple Sclerosis/drug therapy , Multiple Sclerosis/psychology
15.
Anticancer Res ; 21(1A): 317-20, 2001.
Article in English | MEDLINE | ID: mdl-11299755

ABSTRACT

Multidrug resistance (MDR) is one of the major problems in osteosarcoma chemotherapy. Therefore, methods of overcoming MDR are urgently needed. In this study, we investigated the effects of pulsing electromagnetic field stimulation (PEMFs) on a MDR murine osteosarcoma cell line which strongly expresses P-glycoprotein (P-gp). To assess the reversal effects of PEMFs on doxorubicin (DOX) resistance, MTT assay was applied. Viable cells were assessed by the trypan blue exclusion test. Fluorescence intensity of DOX binding to nuclear DNA of each cell was measured using a cytofluorometer. Changes in P-gp expression in each cell were detected by the indirect immunofluorescence method using an antibody to Pgp. PEMFs increased DOX binding ability to nuclear DNA and inhibited cell growth, although it had no significant effect on P-gp expression. These findings indicated that PEMFs reversed the DOX resistance of the MOS/ADR1 cells by inhibiting P-gp function. The results suggested that PEMFs may be useful as a local treatment for MDR osteosarcoma.


Subject(s)
Antineoplastic Agents/therapeutic use , Bone Neoplasms/therapy , Doxorubicin/therapeutic use , Drug Resistance, Multiple , Electromagnetic Fields , Osteosarcoma/therapy , ATP Binding Cassette Transporter, Subfamily B, Member 1/metabolism , Animals , Antineoplastic Agents/metabolism , Bone Neoplasms/drug therapy , Bone Neoplasms/metabolism , Cell Division/drug effects , Cell Nucleus/drug effects , Cell Nucleus/metabolism , Combined Modality Therapy , DNA, Neoplasm/drug effects , DNA, Neoplasm/metabolism , Doxorubicin/metabolism , Drug Resistance, Neoplasm , Mice , Microscopy, Fluorescence , Osteosarcoma/drug therapy , Osteosarcoma/metabolism , Tumor Cells, Cultured
16.
J Biochem ; 129(4): 577-83, 2001 Apr.
Article in English | MEDLINE | ID: mdl-11275557

ABSTRACT

In this study, we attempted to analyze the peptide motifs recognized by 24822.111 and F9, monoclonal antibodies (mAbs) that inhibit the chemotactic activity of monocyte chemoattractant protein-1 (MCP-1), a member of the CC subfamily of chemokines. We isolated phage clones from a phage display library and identified six peptide motifs. One of these clones, C27, was strongly and specifically recognized by 24822.111 mAb, while another, G25, was similarly recognized by F9 mAb. Both the C27 motif and the G25 motif contain two cysteines in their sequences and have little homology to the primary amino acid sequence of MCP-1. These clones, however, bound to THP-1 cells, and the binding was competitively inhibited by MCP-1. The clones strongly inhibited the MCP-1-induced chemotaxis of human monocytes. The synthetic and intramolecularly disulfide-linked peptides of C27 and G25 (sC27 and sG25) also inhibited the chemotaxis induced by MCP-1, while their derivatives with serine in place of cysteine did not, suggesting the importance of the loop structure for the inhibition. These results suggest that sC27 and sG25 may mimic the MCP-1-binding domain to the MCP-1 receptor.


Subject(s)
Chemokine CCL2/antagonists & inhibitors , Chemokine CCL2/chemistry , Molecular Mimicry , Peptides/chemistry , Peptides/pharmacology , Amino Acid Sequence , Antibodies, Monoclonal/immunology , Bacteriophages/genetics , Bacteriophages/metabolism , Binding Sites , Blotting, Western , Cell Line , Chemokine CCL2/immunology , Chemokine CCL2/pharmacology , Chemotaxis/drug effects , Drug Design , Epitopes/chemistry , Epitopes/immunology , Flow Cytometry , Humans , Peptide Library , Peptides/immunology , Peptides/metabolism , Protein Binding , Protein Structure, Tertiary , Receptors, CCR2 , Receptors, Chemokine/metabolism
17.
Osteoarthritis Cartilage ; 9(2): 147-51, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11237661

ABSTRACT

OBJECTIVE: Although it is well known that binuclear cells commonly appear among the chondrocytes of normal cartilages as well as among neoplastic chondrocytes of chondrosarcomas, the mechanism of binucleation is still unclear. Therefore, this study was undertaken to clarify the mechanism of binucleation in chondrocytes, using primary culture cells of growth plate cartilage. DESIGN: These chondrocytes were exposed to acridine orange (AO) which is a fluorescent dye for differentiating certain DNAs and RNAs in nuclei and cytoplasm, and which inhibits mitosis. After exposure to 0.5 microg/ml AO, for 0, 6, 24, 48, and 96 h, the following parameters were investigated: (1) cell growth rate (GR); (2) frequency of hyperdiploid cells (%HDC) by DNA cytofluorometry; (3) mitotic index (MI); (4) BrdU labeling index (LI); (5) frequency of binuclear cells (%BNC). RESULTS: Compared with the control cells, which were cultured in AO-free medium, the GR was remarkably inhibited at 24 h. MI was also decreased from 6 to 24 h, and LI decreased at 48 h. However, these parameters were recovered at 96 h. The %HDC was increased from 6 to 96 h, and the %BNC was also increased to a maximum of six times that of the control cells at 96 h. DISCUSSION: These results suggested that the binuclear cells observed among the cultured chondrocytes may be formed from G2 arrested cells by amitotic nuclear division, but not by mitosis without cytoplasmic division or cell fusion.


Subject(s)
Acridine Orange/pharmacology , Chondrocytes/cytology , Animals , Cattle , Cell Division/drug effects , DNA/metabolism , Mitosis/drug effects
18.
Oncol Rep ; 8(2): 321-4, 2001.
Article in English | MEDLINE | ID: mdl-11182048

ABSTRACT

We examined the survival prognosis of patients with osteosarcoma after orally administering the active form of vitamin D3, 1alpha (OH) D3 (alphaD3). The 29 patients, ranging in age from 9 to 58 years (mean, 19 years), with osteosarcoma were treated in our department between 1983 and 1995. The surgical stage was IIB in all patients. Among the 29 patients, alphaD3 was administered to 18 patients, and the remaining 11 patients served as controls. These patients underwent chemotherapy mainly with adriamycin and cisplatin, and wide tumor resection. In the alphaD3-treated group, the 5- or 10-year survival rate was 61.1%, while in the untreated group, the 5-year survival rate was 63.6%, and 10-year survival rate was 33.9%. Prognosis of the patients treated with alphaD3 tended to be better than that of untreated patients, but there was no significant difference in the survival rate between the groups (p=0.3823). The survival rate in the group treated with a total dose of alphaD3 more than 1,500 microg was also higher than that in the untreated group, but the difference was not significant (p=0.0740). Therefore, we concluded that alphaD3 at the dose used in this study was not effective in improving the prognosis of osteosarcoma patients.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Bone Neoplasms/drug therapy , Bone Neoplasms/surgery , Calcifediol/therapeutic use , Osteosarcoma/drug therapy , Osteosarcoma/surgery , Adolescent , Adult , Bone Neoplasms/mortality , Child , Cisplatin/administration & dosage , Combined Modality Therapy , Doxorubicin/administration & dosage , Female , Follow-Up Studies , Humans , Male , Middle Aged , Osteosarcoma/mortality , Prognosis , Survival Rate , Time Factors
19.
Oncol Rep ; 8(2): 365-8, 2001.
Article in English | MEDLINE | ID: mdl-11182057

ABSTRACT

We demonstrate our procedure of extra-articular wide tumor resection and its clinical outcome. The knee joint including the femorotibial, patellofemoral and the proximal tibiofibular joints was totally resected without any view of articular cartilage and synovium. The resected limb was reconstructed with endoprosthesis of the knee joint. The average score of the limb function evaluated by ISOLS criteria was 69.3% in all patients. The limb function of these patients was almost the same as that of the patients who received the intra-articular procedure. The procedure of extra-articular resection was theoretically necessary and clinically practical.


Subject(s)
Arthroplasty, Replacement, Knee/methods , Bone Neoplasms/pathology , Bone Neoplasms/surgery , Knee Joint/surgery , Knee Prosthesis , Neoplasm Invasiveness , Humans , Knee Joint/pathology , Prosthesis Design
20.
J Pharmacol Exp Ther ; 296(1): 22-30, 2001 Jan.
Article in English | MEDLINE | ID: mdl-11123358

ABSTRACT

A new nonsulfonylurea oral hypoglycemic agent, JTT-608, has been reported to stimulate insulin release at elevated, but not low, glucose concentrations and consequently not to induce hypoglycemia in rats. Accordingly, this drug is potentially a safer antidiabetic agent than sulfonylureas. To explore the mechanisms underlying this glucose-dependent insulinotropism, the present study investigated the effects of JTT-608 on cytosolic free Ca(2+) concentration ([Ca(2+)](i)) and protein kinase A (PKA) activity in rat islet beta-cells by microfluorometry using, respectively, fura-2 and a fluorescence PKA substrate, DR II. In the presence of glucose at normal and elevated concentrations (5.0-16.7 mM) JTT-608 (30-1000 microM) concentration dependently increased [Ca(2+)](i) in up to 88% of single beta-cells, whereas at lower glucose concentrations (2.8 and 4.2 mM) it had little effect. The [Ca(2+)](i) responses were inhibited under Ca(2+)-free conditions and by nitrendipine, an L-type Ca(2+) channel blocker. JTT-608 rapidly activated PKA and a PKA inhibitor, H89, inhibited [Ca(2+)](i) responses to JTT-608. JTT-608 also stimulated insulin release from rat islets in a glucose- and Ca(2+)-dependent manner. The glucose-unresponsive beta-cells, which failed to respond to 8.3 mM glucose with increases in [Ca(2+)](i), were frequently recruited to [Ca(2+)](i) increases by JTT-608. JTT-608 also induced oscillations of [Ca(2+)](i). Glucagon-like peptide-1(7-36)amide (GLP-1), pituitary adenylate cyclase-activating polypeptide (PACAP), and acetylcholine (ACh) enhanced the action of JTT-608 on [Ca(2+)](i). In conclusion, JTT-608 evokes PKA-mediated Ca(2+) influx and Ca(2+) signaling in rat islet beta-cells in a glucose-regulated manner, which may account for its glucose-dependent insulinotropism. JTT-608 and neurohormones may cooperatively activate islet beta-cells under physiological conditions.


Subject(s)
Butyrates/pharmacology , Calcium Signaling/drug effects , Cyclic AMP-Dependent Protein Kinases/metabolism , Cyclohexanes/pharmacology , Glucose/physiology , Hypoglycemic Agents/pharmacology , Insulin/metabolism , Islets of Langerhans/drug effects , Neuropeptides/pharmacology , Peptide Fragments/pharmacology , Acetylcholine/physiology , Animals , Calcium Channel Blockers/pharmacology , Cell Separation , Cells, Cultured , Cyclic AMP-Dependent Protein Kinases/antagonists & inhibitors , Enzyme Activation , Enzyme Inhibitors/pharmacology , Glucagon , Glucagon-Like Peptide 1 , Glucagon-Like Peptides , Islets of Langerhans/metabolism , Pituitary Adenylate Cyclase-Activating Polypeptide , Rats , Rats, Wistar
SELECTION OF CITATIONS
SEARCH DETAIL
...